Venter Sees Japan Playing Leading Role in Golden Age of Discovery | GenomeWeb

TOKYO, March 21 - Craig Venter, Celera Genomics president and chief scientific officer, suggested Wednesday that Japan would play an increasingly significant role in the post-genomic age and indicated his interest in expanding his company’s presence in the country.

Terming the current phase the Golden Age of Discovery in proteomics, disease prevention, and medical treatment, Venter said that Japan “could end up leading the world in terms of the implementation of new ideas in medicine.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.